US Patent Issued to Sigma-Aldrich on April 15 for "Using programmable DNA binding proteins to enhance targeted genome modification" (Missouri Inventor)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,952, issued on April 15, was assigned to Sigma-Aldrich Co. LLC (St. Louis).

"Using programmable DNA binding proteins to enhance targeted genome modification" was invented by Fuqiang Chen (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for using programmable DNA binding proteins to increase the efficiency and/or specificity of targeted genome modification or to facilitate the detection of specific genomic loci in eukaryotic cells."

The patent was filed on Feb. 15, 2019, under Application No. 16/277,638.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-P...